Support for association of HSPG2 with tardive dyskinesia in Caucasian populationsGreenbaum, L; Alkelai, A; Zozulinsky, P; Kohn, Y; Lerer, B · The Pharmacogenomics Journal · 2012

99mTc-HMPAO SPECT Study of Cerebral Perfusion After Treatment with Medication and Electroconvulsive Therapy in Major DepressionKohn, Y.; Freedman, N.; Lester, H.; Krausz, Y.; Chisin, R.; Lerer, B.; Bonne, O. · Journal of Nuclear Medicine · 2007

Dopamine D4 receptor gene polymorphisms: relation to ethnicity, no association with schizophrenia and response to clozapine in Israeli subjectsY Kohn; R.P Ebstein; U Heresco-Levy; B Shapira; L Nemanov; I Gritsenko; M Avnon; B Lerer · 1997

Oxytocin and vasopressin genes are significantly associated with schizophrenia in a large Arab-Israeli pedigree – CORRIGENDUMTeltsh, O; Kanyas-Sarner, K; Rigbi, A; Greenbaum, L; Lerer, B; Kohn, Y · The International Journal of Neuropsychopharmacology · 2013

Fine mapping of AHI1 as a schizophrenia susceptibility gene: from association to evolutionary evidenceTorri, F.; Akelai, A.; Lupoli, S.; Sironi, M.; Amann-Zalcenstein, D.; Fumagalli, M.; Fiume, C. D.; Ben-Asher, E.; Kanyas, K.; Cagliani, R.; Cozzi, P.; Trombetti, G.; Lievers, L. S.; Salvi, E.; Orro, A.; Beckmann, J. S.; Lancet, D.; Kohn, Y.; Milanesi, L.; Ebstein, R. B.; Lerer, B.; Macciardi, F. · The FASEB Journal · 2010

The trace amine receptor 4 gene is not associated with schizophrenia in a sample linked to chromosome 6q23Amann, D; Avidan, N; Kanyas, K; Kohn, Y; Hamdan, A; Ben-Asher, E; Macciardi, F; Beckmann, J S; Lancet, D; Lerer, B · 2005

Genome scan of Arab Israeli families maps a schizophrenia susceptibility gene to chromosome 6q23 and supports a locus at chromosome 10q24Lerer, B; Segman, R H; Hamdan, A; Kanyas, K; Karni, O; Kohn, Y; Korner, M; Lanktree, M; Kaadan, M; Turetsky, N · 2003